Table 5

Pooled estimate of the association between obesity and COVID-19 outcomes in the general population by region (n=150)

Exposure by regionHospital admission+ICU+IMV*DeathStudies with combinations of outcomes†
Studies (n)Pooled OR (95% CI)Studies (n)Pooled OR (95% CI)Studies (n)Pooled OR (95% CI)
BMI continuous (5 units)
 Asian-Pacific014.32 (1.05 to 17.9)52.49 (1.76 to 3.44)
 Europe31.28 (1.00 to 1.61)51.16 (1.00 to 1.28)31.22 (0.95 to 1.54)
 North America11.28 (1.16 to 1.47)81.05 (0.95 to 1.16)21.10 (0.90 to 1.28)
Overweight
 Asian-Pacific10.84 (0.46 to 1.55)10.53 (0.14, 2.00)31.16 (1.00 to 1.33)
 Europe32.11 (1.28 to 3.46)61.14 (0.93 to 1.39)21.68 (0.78 to 3.65)
 North America151.18 (1.10 to 1.25)141.00 (0.88 to 1.14)31.03 (0.82 to 1.29)
Obese
 Asian-Pacific32.35 (1.17 to 1.56)51.73 (1.36 to 2.20)92.37 (1.60 to 3.53)
 Europe142.64 (1.81 to 3.86)241.43 (1.14 to 1.79)51.42 (1.24 to 1.63)
 North America341.52 (1.45 to 1.59)411.13 (1.04 to 1.22)61.38 (1.18 to 1.62)
Extreme obese
 Asian-Pacific014.32 (1.37 to 13.61)0
 Europe24.08 (2.13 to 7.82)52.56 (2.11 to 3.11)12.30 (1.20 to 4.40)
 North America92.25 (1.91 to 2.65)131.81 (1.57 to 2.08)31.66 (1.44 to 1.93)
Non-BMI-defined obesity‡
 Asian-Pacific0012.47 (1.02 to 5.98)
 Europe41.32 (1.16 to 1.49)031.63 (1.00 to 2.66)
 North America012.00 (1.32 to 3.02)11.28 (0.92 to 1.79)
  • *Pooled studies included in-hospital admission, ICU and IMV. The estimates for hospital admission, ICU and IMV were not shown separately because of low number of studies.

  • †Studies whose endpoint was the combination of two or more of the following: hospital admission, ICU, IMV, death or other conditions pertaining to a severe disease.

  • ‡Non-BMI-defined obesity includes neck circumference, waist circumference, waist-to-hip ratio and visceral adipose tissue.

  • BMI, body mass index; ICU, intensive care unit; IMV, invasive mechanical ventilation.